相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Antithrombotic Therapy for VTE Disease Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence- Based Clinical Practice Guidelines
Clive Kearon et al.
CHEST (2012)
Treatment and Prevention of Heparin-Induced Thrombocytopenia Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
Lori-Ann Linkins et al.
CHEST (2012)
Outcome of incidentally diagnosed pulmonary embolism in patients with malignancy
Paul L. den Exter et al.
CURRENT OPINION IN PULMONARY MEDICINE (2012)
Unsuspected pulmonary embolism: impact on mortality among cancer patients
Caroline Piatek et al.
CURRENT OPINION IN PULMONARY MEDICINE (2012)
Outpatient Use of Low Molecular Weight Heparin Monotherapy for First-Line Treatment of Venous Thromboembolism in Advanced Cancer
Thomas Delate et al.
ONCOLOGIST (2012)
Long-term Low-Molecular-Weight Heparin and the Post-Thrombotic Syndrome: A Systematic Review
Russell D. Hull et al.
AMERICAN JOURNAL OF MEDICINE (2011)
Protamine neutralisation of low molecular weight heparins and their oligosaccharide components
Mette Schroeder et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2011)
Unsuspected pulmonary emboli adversely impact survival in patients with cancer undergoing routine staging multi-row detector computed tomography scanning
C. O'Connell et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2011)
Long-term anticoagulation treatment for acute venous thromboembolism in patients with and without cancer The SWIss Venous ThromboEmbolism Registry (SWIVTER) II
David Spirk et al.
THROMBOSIS AND HAEMOSTASIS (2011)
Symptomatic and incidental thromboembolism are both associated with mortality in pancreatic cancer
Laurel A. Menapace et al.
THROMBOSIS AND HAEMOSTASIS (2011)
Tinzaparin Sodium A Review of its Use in the Prevention and Treatment of Deep Vein Thrombosis and Pulmonary Embolism, and in the Prevention of Clotting in the Extracorporeal Circuit during Haemodialysis
Sheridan M. Hoy et al.
DRUGS (2010)
A real-world evaluation of the effectiveness of dalteparin in the prevention of recurrent venous thromboembolism compared to warfarin in patients with cancer.
W. R. Simons et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Prevalence and Clinical History of Incidental, Asymptomatic Pulmonary Embolism: A Meta-Analysis
F. Dentali et al.
THROMBOSIS RESEARCH (2010)
Home Therapy of Venous Thrombosis with Long-term LMWH versus Usual Care: Patient Satisfaction and Post-thrombotic Syndrome
Russell D. Hull et al.
AMERICAN JOURNAL OF MEDICINE (2009)
Cancer and thrombosis: implications of published guidelines for clinical practice
A. A. Khorana
ANNALS OF ONCOLOGY (2009)
Does clinical method mask significant VTE-related mortality and morbidity in malignant disease?
A. Maraveyas et al.
BRITISH JOURNAL OF CANCER (2009)
The Incidence and Risk of Venous Thromboembolism Associated With Cancer and Nonsurgical Cancer Treatment
Anna Falanga
CANCER INVESTIGATION (2009)
Anticoagulation therapy for prevention and treatment of venous thromboembolic events in cancer patients: A review of current guidelines
Lars J. Petersen
CANCER TREATMENT REVIEWS (2009)
A Randomised Open-Label Trial Comparing Long-term Sub-Cutaneous Low-Molecular-weight Heparin Compared with Oral-Anticoagulant Therapy in the Treatment of Deep Venous Thrombosis
A. Romera et al.
EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY (2009)
Thromboembolic events in patients with cervical carcinoma: Incidence and effect on survival
Geraldine Jacobson et al.
GYNECOLOGIC ONCOLOGY (2009)
Anticoagulation in the Treatment of Established Venous Thromboembolism in Patients With Cancer
Agnes Y. Y. Lee
JOURNAL OF CLINICAL ONCOLOGY (2009)
Thromboembolism in Patients With Advanced Gastroesophageal Cancer Treated With Anthracycline, Platinum, and Fluoropyrimidine Combination Chemotherapy: A Report From the UK National Cancer Research Institute Upper Gastrointestinal Clinical Studies Group
Naureen Starling et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Assessing Risk of Venous Thromboembolism in the Patient With Cancer
Alok A. Khorana et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Dose escalation of low molecular weight heparin to manage recurrent venous thromboembolic events despite systemic anticoagulation in cancer patients
M. Carrier et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
Clinical characteristics and management of cancer-associated acute venous thromboembolism: findings from the MASTER Registry
Davide Imberti et al.
HAEMATOLOGICA (2008)
Risk of Venous Thromboembolism With the Angiogenesis Inhibitor Bevacizumab in Cancer Patients A Meta-analysis
Shobha Rani Nalluri et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
American society of clinical oncology guideline: Recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer
Gary H. Lyman et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Self-managed long-term low-molecular-weight heparin therapy: The balance of benefits and harms
Russell D. Hull et al.
AMERICAN JOURNAL OF MEDICINE (2007)
Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy
A. A. Khorana et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Long-term low-molecular-weight heparin versus usual care in proximal-vein thrombosis patients with cancer
Russell D. Hull et al.
AMERICAN JOURNAL OF MEDICINE (2006)
Is recurrent venous thromboembolism after therapy reduced by low-molecular-weight heparin compared with oral anticoagulants?
Gianluigi Ferretti et al.
CHEST (2006)
Unsuspected pulmonary emboli in cancer patients: Clinical correlates and relevance
Casey L. O'Connell et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Secondary prevention of venous thromboembolic events in patients with active cancer: Enoxaparin alone versus initial enoxaparin followed by warfarin for a 180-day period
Steven R. Deitcher et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2006)
Incidence of venous thrombosis in a large cohort of 66 329 cancer patients:: results of a record linkage study
JW Blom et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
Risk factors for chemotherapy-associated venous thromboembolism in a prospective observational study
AA Khorana et al.
CANCER (2005)
Long-term treatment of deep venous thrombosis with a low molecular weight heparin (Tinzaparin): A prospective randomized trial
ME Daskalopoulos et al.
EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY (2005)
A Randomized trial comparing 2 low-molecular-weight heparins for the outpatient treatment of deep vein thrombosis and pulmonary embolism
PS Wells et al.
ARCHIVES OF INTERNAL MEDICINE (2005)
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients
S Schulman et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
Malignancies, prothrombotic mutations, and the risk of venous thrombosis
JW Blom et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Is long-term low-molecular-weight heparin acceptable to palliative care patients in the treatment of cancer related venous thromboembolism? A qualitative study
SIR Noble et al.
PALLIATIVE MEDICINE (2005)
Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer
AYY Lee et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis
P Prandoni et al.
BLOOD (2002)
Comparison of low-molecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer - A randomized controlled study
G Meyer et al.
ARCHIVES OF INTERNAL MEDICINE (2002)
Mechanisms responsible for the failure of protamine to inactivate low-molecular-weight heparin
MA Crowther et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
Safety profile of tinzaparin administered once daily at a standard curative dose in two hundred very elderly patients
E Pautas et al.
DRUG SAFETY (2002)
Prognosis of cancers associated with venous thromboembolism.
HT Sorensen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Incidence of recurrent thromboembolic and bleeding complications among patients with venous thromboembolism in relation to both malignancy and achieved international normalized ratio: A retrospective analysis
BA Hutten et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
分享论文
